MILAN MRKSICH was appointed associate director for research technology and infrastructure at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Mrksich is the Henry Wade Rogers Professor of Biomedical Engineering, Chemistry and Cell and Molecular Biology, with appointments in the McCormick School of Engineering and Applied Science, Weinberg College of Arts and Sciences, and Feinberg School of Medicine.
He will be responsible for oversight of the Lurie Cancer Center’s research shared resource facilities. Currently, 15 shared resource facilities are supported by the Lurie Cancer Center, including the Center for Advanced Microscopy, Medicinal & Synthetic Chemistry Core, Targeted Transgenic & Mutagenesis Laboratory, and the High Throughput Analysis Laboratory.
Mrksich’s research combines synthetic chemistry with materials science to study important problems in cell biology. He is a co-founder of Arsenal Medical Inc., a medical devices company that has a stent product in clinical trials, and recently co-founded SAMDI Tech, an early-stage technology company based on his new platform for analyzing biochemical reactions.
